Background Chronic kidney disease (CKD) patients have a high incidence of cardiovascular
disease (CVD) events, which is related to the inflammatory status of this population. Platelet …

Objectives. The monocyte-to-lymphocyte ratio (MLR), as a new marker of the systemic
inflammatory response, is associated with cardiovascular disease (CVD) mortality in the …

Neutrophil‐to‐lymphocyte ratio (NLR) was introduced as a potential marker to determine
inflammation in end‐stage renal disease (ESRD) patients. Recently, platelet‐to‐lymphocyte …

Peritoneal dialysis (PD) is one of the major treatments for end-stage renal disease (ESRD)
patients. 1 Compared with the general population, ESRD patients have a higher risk of …

Background The monocyte-to-lymphocyte ratio (MLR) is considered as a new inflammation
marker. This study was aimed to investigate the prognostic value of MLR for all-cause …

Objective The mean platelet volume/ratio (MPVLR) is recognized as a novel marker of
inflammation. We evaluated whether the MPVLR is associated with inflammation in non …

Purpose Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were
established showing the poor prognosis in some diseases, such as cardiovascular diseases …

Introduction: It is believed that the excessive cardiovascular (CV) burden of patients on
peritoneal dialysis (PD) is closely associated with chronic inflammation. Neutrophil …

Background Neutrophil to lymphocyte ratio (NLR) is widely used as a marker of inflammation
and an indicator of cardiovascular outcomes in patients with coronary artery disease …

Background. Neutrophil to lymphocyte ratio (NLR) is a new inflammatory marker; the
relationship between NLR and adverse cardiovascular (CV) prognosis has been gradually …